DeFord John A reported grant involving 46,293 shares of MARAVAI LIFESCIENCES HOLDINGS, INC. at $0.00 for $0 on May 26, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
46,293Class A Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
205,478Direct
Trade date
May 26, 2026Grant
Filed
May 28, 2026, 6:20 PM ET2-day reporting delay
Accession
0001403373-26-000005Code A · Transaction 387227
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MRVI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MRVI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −23%1w ago −9.1%1d ago −5.2%
Returns since7d +7.5%30d +34%90d +92%180d1y

Footnotes in full

F1: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.